...
首页> 外文期刊>Therapeutic delivery >Development and characterization of sublingual films for enhanced bioavailability of selegiline hydrochloride
【24h】

Development and characterization of sublingual films for enhanced bioavailability of selegiline hydrochloride

机译:舌下胶片增强盐酸苯甲醚生物利用度的发展与鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

Low oral bioavailability of selegiline hydrochloride (SH) is primarily due to extensive first-pass metabolism and hence the need for an alternative pathway of administration. Herein, we report the development of sublingual SH films. The films were formulated with varying polymer composition (F1-F6) and evaluated for physicochemical characteristics, in vitro drug release and ex vivo permeation studies. The film F2 demonstrated satisfactory weight (10.60 mg), folding endurance (>200), drug content (11.44 mg/cm(2)), disintegration time (68 s), mucoadhesive strength (47.7 N/cm(2)), and controlled release for 30 min. The permeation studies exhibited a higher ex vivo sublingual flux than that of the plain drug. This study concludes that the SH film can provide a potential opportunity for sublingual drug delivery.
机译:盐酸司来吉兰(SH)口服生物利用度低主要是由于广泛的首过代谢,因此需要一种替代给药途径。在此,我们报告了舌下SH片的发展。薄膜由不同的聚合物组成(F1-F6)制成,并评估其理化特性、体外药物释放和体外渗透研究。薄膜F2显示出令人满意的重量(10.60 mg)、耐折叠性(>200)、药物含量(11.44 mg/cm(2))、崩解时间(68 s)、粘膜粘附强度(47.7 N/cm(2))和30 min的控释。渗透研究显示,离体舌下通量高于普通药物。这项研究得出结论,SH膜可以为舌下给药提供潜在的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号